Back
INmune Bio Vs. Monopar Therapeutics Industry Stock Comparison
Sell
35
INMB
INmune Bio
Last Price:
$7.44
Seasonality Move:
31.04%
Buy
51
MNPR
Monopar Therapeutics
Last Price:
$38.36
Seasonality Move:
-0.36%
Sell
35
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $7.56. The Score for INMB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.49. The Score for MNPR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $7.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INMB is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
INMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 48.84 | Sell |
Chaikin Money Flow: | 116084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 54.18 | Buy |
Chaikin Money Flow: | 15636 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
INMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.31 | Buy |
20-day SMA: | 7.68 | Sell |
50-day SMA: | 8.3 | Sell |
200-day SMA: | 6.79 | Buy |
8-day EMA: | 7.38 | Buy |
20-day EMA: | 7.61 | Sell |
50-day EMA: | 7.68 | Sell |
200-day EMA: | 7.41 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.41 | Buy |
20-day SMA: | 36.04 | Buy |
50-day SMA: | 37.32 | Buy |
200-day SMA: | 18.94 | Buy |
8-day EMA: | 34.05 | Buy |
20-day EMA: | 34.56 | Buy |
50-day EMA: | 34.44 | Buy |
200-day EMA: | 23.13 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.16 per share, an increase this year of $0.44 per share, and an increase next year of $0.09 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
INmune Bio Technical Analysis
Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |